In vitro anti-cancer property of five synthetic cantharidin analogues: A mini-review

Minerva Biotecnologica

Volumn 18, Issue 3, 2006, Pages 153-157

  Kok, S H L ^a,e   Gambari, R ^b   Chui, C H ^a,c,e   Lam, W S ^a,e   Chen, J ^a,e   Lau, F Y ^c   Wong, R S M ^c   Cheng, G Y M ^c   Lai, P B S ^c   Leung, T W T ^d   Chan, A S C ^a,e   Tang, J C O ^a,e  

^a State Key Laboratory of Chinese Medicine and Molecular Pharmacology   (China)

^b UNIVERSITY OF FERRARA   (Italy)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d HONG KONG SANATORIUM AND HOSPITAL   (Hong Kong)

^e HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

Author keywords

Cantharidin; Neoplasms; Structural activity relationship

Indexed keywords

ANTINEOPLASTIC AGENT; CAN 029; CAN 030; CAN 032; CAN 036; CAN 037; CANTHARIDIN; CANTHARIDIN DERIVATIVE; CYTOTOXIC AGENT; PLATINUM COMPLEX; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BREAST CANCER; CARCINOMA CELL; CYTOTOXICITY; DRUG DESIGN; DRUG MECHANISM; DRUG RESEARCH; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; LEUKEMIA CELL; LIVER CELL CARCINOMA; LUNG NON SMALL CELL CANCER; REVIEW; STRUCTURE ACTIVITY RELATION;

HEXAPODA; MYLABRIS;

EID: 33847737361     PISSN: 11204826     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (12)

1. Tsauer W, Lin JG, Lin PY, Hsu FL, Chiang HC. The effects of cantharidin analogues on xanthine oxidase. Anticancer Res 1997;17: 2095-8.
2. Zhang SQ. A study on antitumor chemotherapeutic agents: synthesis of N-cantharidine derivatives. Yao Xue Xue Bao 1981;16: 784-6.
3. Wang GS. Medical uses of Mylabris in ancient China and recent studies. J Ethnopharm 1989;26:147-62.
4. Wang GS. Hydrolysis and demethylation of cantharidin, a protein on the relief of the urinary irritation. Chem Pharma Bull 1983;7: 18-9.
5. Lin LH, Huang HS, Lin CC, Lee LW, Lin PY. Effects of cantharidinimides on human carcinoma cells. Chem Pharm Bull 2004;52: 855-7.
6. Lin PY, Shi SJ, Shu HL, Chen HF, Lin CC, Liu PC et al. A simple procedure for preparation of N-Thiazoyl and N-Thiadiazolycantha-ridinimides and evaluation of their cytotoxicities against human hepatocellular carcinoma cells. Bioorganic Chem 2000;28:266-72.
7. Kok SHL, Chui CH, Lam WS, Chen J, Tang JCO, Lau FY et al. Induction of apoptosis on carcinoma cells by two synthetic cantharidin analogues. Int J Mol Med 2006;17:151-7.
8. Kok SHL, Chui CH, Lam WS, Chen J, Lau FY, Cheng GYM et al. Apoptotic activity of a novel synthetic cantharidin analogue on hepatoma cell lines. Int J Mol Med 2006;17:945-9.
9. Kok SHL, Chui CH, Lam WS, Chen J, Lau FY, Wong RSM et al. Mechanistic insight into a novel synthetic cantharidin analogue in a leukaemia model. Int J Mol Med 2006;18:375-9.
10. Kok SHL, Chui CH, Lam WS, Chen J, Lau FY, Wong RSM et al. Apoptogenic activity of a synthetic cantharimide in leukemia: Implication on its structural activity relationship. Int J Mol Med 2006;18:1217-21.
11. Ho YP, To KKW, Au Yeung SCF, Wang X, Lin G, Han X. Potential new antitumor agents from an innovative combination of demethylcantharidin, a modified Traditional Chinese Medicine, a with platinum moiety. J Med Chem 2001;44:2065-8.
12. Yu CW, Li KK, Pang SK, Au Yeung SCF, Ho YP. Anticancer activity of a series of platinum complexes integrating demethylcantharidin with isomers of 1,2-diaminocyclohexane. Bioorg Med Chem Lett 2006;16:1686-91.